# Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma

> **NCT07034755** · NA · NOT_YET_RECRUITING · sponsor: **The Affiliated Hospital of Xuzhou Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Multiple Myeloma (MM)
- Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
- Chimeric Antigen Receptor T-cell

## Interventions

- **OTHER:** autologous hematopoietic stem cell transplantation (ASCT) followed by CAR-T therapy

## Key facts

- **NCT ID:** NCT07034755
- **Lead sponsor:** The Affiliated Hospital of Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07034755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07034755, "Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07034755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*